Surasak Phuphanich

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

David A. Reardon, Alba A. Brandes, Antonio Omuro et al. · JAMA Oncology · 2020 · 1.5K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

Tracy T. Batchelor, Paul Mulholland, Bart Neyns et al. · Journal of Clinical Oncology · 2013 · 598 citations · Full text

Medicine, Oncology, Pharmacology +17

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain et al. · PubMed · 1999 · 528 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Albert Lai, Anh Tran, Phioanh L. Nghiemphu et al. · Journal of Clinical Oncology · 2010 · 452 citations · Full text

Medicine, Oncology, Radiation Oncology +16

A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

E. Antonio Chiocca, Khalid M. Abbed, Stephen B. Tatter et al. · Molecular Therapy · 2004 · 440 citations · Full text

Medicine, Oncology, Pharmacotherapy +13